SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unilife Corp – ‘10-Q’ for 9/30/13 – ‘EX-101.INS’

On:  Tuesday, 11/12/13, at 5:16pm ET   ·   For:  9/30/13   ·   Accession #:  1193125-13-438524   ·   File #:  1-34540

Previous ‘10-Q’:  ‘10-Q’ on 5/10/13 for 3/31/13   ·   Next:  ‘10-Q’ on 2/10/14 for 12/31/13   ·   Latest:  ‘10-Q’ on 2/9/17 for 12/31/16

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/12/13  Unilife Corp                      10-Q        9/30/13   52:2.7M                                   Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    208K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     22K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     18K 
51: R1          Document and Entity Information                     HTML     39K 
36: R2          Consolidated Balance Sheets                         HTML    111K 
33: R3          Consolidated Balance Sheets (Parenthetical)         HTML     42K 
14: R4          Consolidated Statements of Operations and           HTML     65K 
                Comprehensive Loss                                               
35: R5          Consolidated Statement of Stockholders' Equity      HTML     54K 
23: R6          Consolidated Statements of Cash Flows               HTML     92K 
45: R7          Description of Business and Unaudited Financial     HTML     22K 
                Statements                                                       
24: R8          Liquidity                                           HTML     24K 
26: R9          Summary of Significant Accounting Policies          HTML     30K 
15: R10         Equity Transactions and Share-Based Compensation    HTML     56K 
25: R11         Property, Plant and Equipment and                   HTML     29K 
                Construction-in-Progress                                         
44: R12         Goodwill and Intangible Assets                      HTML     27K 
41: R13         Long-Term Debt                                      HTML     36K 
34: R14         Net Loss Per Share                                  HTML     30K 
48: R15         Contingencies                                       HTML     29K 
43: R16         Business Alliances                                  HTML     22K 
12: R17         Summary of Significant Accounting Policies          HTML     51K 
                (Policies)                                                       
17: R18         Equity Transactions and Share-Based Compensation    HTML     52K 
                (Tables)                                                         
47: R19         Property, Plant and Equipment and                   HTML     28K 
                Construction-in-Progress (Tables)                                
50: R20         Goodwill and Intangible Assets (Tables)             HTML     22K 
52: R21         Long-Term Debt (Tables)                             HTML     30K 
49: R22         Net Loss Per Share (Tables)                         HTML     26K 
38: R23         Liquidity - Additional Information (Detail)         HTML     27K 
16: R24         Equity Transactions and Share-Based Compensation -  HTML     45K 
                Additional Information (Detail)                                  
22: R25         Equity Transactions and Share-Based Compensation -  HTML     50K 
                Schedule of Stock Options Activity by Employees                  
                and Directors (Detail)                                           
19: R26         Equity Transactions and Share-Based Compensation -  HTML     50K 
                Schedule of Stock Options Activity by Other than                 
                Employees and Directors (Detail)                                 
18: R27         Equity Transactions and Share-Based Compensation -  HTML     31K 
                Fair Value of Options Granted (Detail)                           
27: R28         Equity Transactions and Share-Based Compensation -  HTML     40K 
                Summary of Activity Related to Restricted Stock                  
                Awards (Detail)                                                  
37: R29         Property, Plant and Equipment and                   HTML     45K 
                Construction-in-Progress - Components of Property,               
                Plant and Equipment and Construction-in-Progress                 
                (Detail)                                                         
42: R30         Goodwill and Intangible Assets - Changes in         HTML     23K 
                Carrying Amount of Goodwill (Detail)                             
21: R31         Goodwill and Intangible Assets - Additional         HTML     24K 
                Information (Detail)                                             
28: R32         Long-Term Debt - Components of Long-Term Debt       HTML     32K 
                (Detail)                                                         
46: R33         Long-Term Debt - Components of Long-Term Debt       HTML     29K 
                (Parenthetical) (Detail)                                         
20: R34         Long-Term Debt - Additional Information (Detail)    HTML     66K 
39: R35         Net Loss Per Share - Net Loss Per Share (Detail)    HTML     36K 
40: R36         Net Loss Per Share - Additional Information         HTML     26K 
                (Detail)                                                         
29: R37         Business Alliances - Additional Information         HTML     29K 
                (Detail)                                                         
32: XML         IDEA XML File -- Filing Summary                      XML     75K 
13: EXCEL       IDEA Workbook of Financial Reports                  XLSX     84K 
31: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    281K 
 6: EX-101.INS  XBRL Instance -- unis-20130930                       XML    494K 
 8: EX-101.CAL  XBRL Calculations -- unis-20130930_cal               XML    129K 
 9: EX-101.DEF  XBRL Definitions -- unis-20130930_def                XML    271K 
10: EX-101.LAB  XBRL Labels -- unis-20130930_lab                     XML    697K 
11: EX-101.PRE  XBRL Presentations -- unis-20130930_pre              XML    493K 
 7: EX-101.SCH  XBRL Schema -- unis-20130930                         XSD     99K 
30: ZIP         XBRL Zipped Folder -- 0001193125-13-438524-xbrl      Zip     79K

‘EX-101.INS’   —   XBRL Instance — unis-20130930

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="yes" encoding="windows-1252"?>
<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1 http://www.rrdonnelley.com/ -->
<!-- Version: 6.21.0 -->
<!-- Round: 5 -->
<!-- Creation date: 2013-11-12T21:35:20Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley & Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:unis="http://unilife.com/20130930" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2013-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
<xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="unis-20130930.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase"/>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20101031_0_931308x1134098" unitRef="iso4217_USD" decimals="-4" id="id_2375738_726C8897-D843-4F77-81F5-95520553680C_3_1"> 3750000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20101031_0_931308x960914" unitRef="iso4217_USD" decimals="-4" id="id_2375738_726C8897-D843-4F77-81F5-95520553680C_2_1"> 14250000 </us-gaap:LongTermDebt>
<unis:AggregatePotentialOfferingPriceOfCommonStock contextRef="eol_PE815564--1310-Q0008_STD_0_20121031_0_926437x923140" unitRef="iso4217_USD" decimals="-5" id="id_2375738_97F09641-9240-4BA2-92E4-B835EBE32117_1_0"> 45000000 </unis:AggregatePotentialOfferingPriceOfCommonStock>
<dei:EntityCommonStockSharesOutstanding contextRef="eol_PE815564--1310-Q0008_STD_0_20131108_0" unitRef="shares" decimals="INF" id="id_2375738_C46EC53F-7344-47D1-AA7E-8896EE6F07C9_2_5"> 100491541 </dei:EntityCommonStockSharesOutstanding>
<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="eol_PE815564--1310-Q0008_STD_0_20110831_0_924420x1135205" unitRef="iso4217_USD" decimals="-5" id="id_2375738_6C704CD2-1D15-4AFD-8016-775B5536F13E_2001_0"> 10000000 </us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
<unis:CommonStockReservedForFutureIssuance contextRef="eol_PE815564--1310-Q0008_STD_0_20091130_0" unitRef="shares" decimals="INF" id="id_2375738_75EE642A-93DC-4FD1-8432-155897F89482_1001_400000"> 6000000 </unis:CommonStockReservedForFutureIssuance>
<us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="eol_PE815564--1310-Q0008_STD_0_20101231_0_926396x955913" unitRef="pure" decimals="INF" id="id_2375738_73C09F1D-AD87-4322-B4C6-40EF5A8DAA01_2002_2"> 0.0500 </us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE815564--1310-Q0008_STD_0_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1002_27"> 18458000 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CommonStockSharesOutstanding contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_33"> 100491541 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesIssued contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_32"> 100520211 </us-gaap:CommonStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="shares" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_28"/>
<us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_26"> 50000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_31"> 250000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:TreasuryStockShares contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_38"> 28670 </us-gaap:TreasuryStockShares>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_30"> 0.01 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_25"> 0.01 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesIssued contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="shares" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_27"/>
<us-gaap:PreferredStockValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_24"/>
<us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_15"> 3720000 </us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:LongTermDebtNoncurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_19"> 19752000 </us-gaap:LongTermDebtNoncurrent>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_8"> 10510000 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:AccountsPayableCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_14"> 1909000 </us-gaap:AccountsPayableCurrent>
<us-gaap:LiabilitiesCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_18"> 8463000 </us-gaap:LiabilitiesCurrent>
<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_36"> 2718000 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_39"> 40153000 </us-gaap:StockholdersEquity>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_34"> 283646000 </us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:DeferredRevenue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_20"> 5050000 </us-gaap:DeferredRevenue>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_35"> -247076000 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:DeferredRevenueCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_17"> 115000 </us-gaap:DeferredRevenueCurrent>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_75B3E4E8-273E-4C33-81E2-5E4E26D3633E_1001_1"> 100000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:CommonStockValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_29"> 1005000 </us-gaap:CommonStockValue>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_40"> 73418000 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_6001_16"> 22471000 </us-gaap:LongTermDebt>
<us-gaap:Liabilities contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_21"> 33265000 </us-gaap:Liabilities>
<us-gaap:CommitmentsAndContingencies contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_22"/>
<us-gaap:LongTermDebtCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_16"> 2719000 </us-gaap:LongTermDebtCurrent>
<us-gaap:AssetsCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_6"> 14797000 </us-gaap:AssetsCurrent>
<us-gaap:Goodwill contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_8"> 11712000 </us-gaap:Goodwill>
<us-gaap:LeaseholdImprovementsGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_6"> 166000 </us-gaap:LeaseholdImprovementsGross>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_9"> 23000 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:OtherAssetsNoncurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_10"> 1162000 </us-gaap:OtherAssetsNoncurrent>
<us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_2"> 1966000 </us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="0" id="id_2375738_75B3E4E8-273E-4C33-81E2-5E4E26D3633E_1001_2"> 7000 </us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
<us-gaap:Land contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_5"> 2036000 </us-gaap:Land>
<us-gaap:Assets contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_11"> 73418000 </us-gaap:Assets>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_1"> 7416000 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:FurnitureAndFixturesGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_3"> 556000 </us-gaap:FurnitureAndFixturesGross>
<us-gaap:BuildingsAndImprovementsGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_0"> 32188000 </us-gaap:BuildingsAndImprovementsGross>
<us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_3"> 5059000 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:InventoryNet contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_4"> 72000 </us-gaap:InventoryNet>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_7"> 56234000 </us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_5"> 284000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_2"> 2653000 </us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:ConstructionInProgressGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_4"> 272000 </us-gaap:ConstructionInProgressGross>
<us-gaap:MachineryAndEquipmentGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_1_1"> 18363000 </us-gaap:MachineryAndEquipmentGross>
<us-gaap:TreasuryStockValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_37"> 140000 </us-gaap:TreasuryStockValue>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_1_7"> 45724000 </us-gaap:PropertyPlantAndEquipmentNet>
<unis:MinimumBalanceRequiredInDebtServiceReserveAccount contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_60463AF0-ADD7-474A-A16E-341B9EB41B59_1001_1"> 1600000 </unis:MinimumBalanceRequiredInDebtServiceReserveAccount>
<unis:AmountOfLoanGuaranteedByDepartmentOfAgriculture contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_60463AF0-ADD7-474A-A16E-341B9EB41B59_1001_2"> 10000000 </unis:AmountOfLoanGuaranteedByDepartmentOfAgriculture>
<unis:DebtServiceReserveAccount contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_60463AF0-ADD7-474A-A16E-341B9EB41B59_1001_0"> 2400000 </unis:DebtServiceReserveAccount>
<unis:RemainingAmountAvailableUnderSalesAgreement contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_97F09641-9240-4BA2-92E4-B835EBE32117_3_3"> 19200000 </unis:RemainingAmountAvailableUnderSalesAgreement>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_926396x959606" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_7001_15"> 376000 </us-gaap:LongTermDebt>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_926396x970115" unitRef="pure" decimals="INF" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_8001_13"> 0.0500 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_926396x970115" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_8001_12"> 2121000 </us-gaap:LongTermDebt>
<unis:StockPriceRequirementForVestingOfOptions contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_926437x923140" unitRef="iso4217_AUD_per_shares" decimals="INF" id="id_2375738_C3EDCAFB-7CB1-4962-B0F7-07308047D417_3001_1"> 3.22 </unis:StockPriceRequirementForVestingOfOptions>
<unis:StockPriceRequirementForVestingOfOptions contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_926437x932953" unitRef="iso4217_AUD_per_shares" decimals="INF" id="id_2375738_C3EDCAFB-7CB1-4962-B0F7-07308047D417_4001_0"> 1.75 </unis:StockPriceRequirementForVestingOfOptions>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x923434" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_3005_800011"> 2718000 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x924490" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_3006_900011"> -140000 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x929313" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_3004_700011"> -247076000 </us-gaap:StockholdersEquity>
<us-gaap:SharesIssued contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x930643" unitRef="shares" decimals="INF" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_3001_400012"> 100520211 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x930643" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_3001_500011"> 1005000 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x932586" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_3003_600011"> 283646000 </us-gaap:StockholdersEquity>
<us-gaap:RecordedUnconditionalPurchaseObligationMinimumQuantityRequired contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_928294x1006168" unitRef="Product" decimals="-6" id="id_2375738_4AF28C1B-ECC9-41D1-AEE7-F517BA00FC61_1_1"> 150000000 </us-gaap:RecordedUnconditionalPurchaseObligationMinimumQuantityRequired>
<unis:MilestoneBasedPayments contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_928294x1006168" unitRef="iso4217_USD" decimals="-6" id="id_2375738_4AF28C1B-ECC9-41D1-AEE7-F517BA00FC61_1_2"> 15000000 </unis:MilestoneBasedPayments>
<unis:MilestoneBasedPaymentsReceived contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_928294x1006168" unitRef="iso4217_USD" decimals="-5" id="id_2375738_4AF28C1B-ECC9-41D1-AEE7-F517BA00FC61_1_3"> 5000000 </unis:MilestoneBasedPaymentsReceived>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_929038x923936" unitRef="shares" decimals="INF" id="id_2375738_8652DEB7-AF0D-4F69-AC75-6CA30AB1B512_1001_4"> 2902153 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_929038x923936" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_E918207F-BB05-485A-9674-06536AE8DDBA_1001_4"> 3.32 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1022497" unitRef="shares" decimals="INF" id="id_2375738_A797CAC9-B14F-40C3-8662-D5E61F79623B_1001_4"> 1332274 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1022497" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_EF03F353-A443-4E98-B1CB-BEE6704D2988_1001_3"> 4.80 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1022497" unitRef="shares" decimals="INF" id="id_2375738_A797CAC9-B14F-40C3-8662-D5E61F79623B_1001_3"> 3797411 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1022497" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_EF03F353-A443-4E98-B1CB-BEE6704D2988_1001_4"> 5.32 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1022497" unitRef="iso4217_USD" decimals="-3" id="id_2375738_64BED409-81EF-40A1-8B6A-C1687A8020B0_1001_1"> 60000 </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1022497" unitRef="iso4217_USD" decimals="-3" id="id_2375738_64BED409-81EF-40A1-8B6A-C1687A8020B0_1001_0"> 516000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1031369" unitRef="shares" decimals="INF" id="id_2375738_AA8112E3-B667-463C-A821-C6EC6F31D4B1_1001_4"> 3503937 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1031369" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_DB50016A-717F-4207-A6D7-809134EC1DDC_1001_3"> 6.98 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1031369" unitRef="shares" decimals="INF" id="id_2375738_AA8112E3-B667-463C-A821-C6EC6F31D4B1_1001_3"> 4503937 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1031369" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_DB50016A-717F-4207-A6D7-809134EC1DDC_1001_4"> 7.30 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1031369" unitRef="iso4217_USD" decimals="-3" id="id_2375738_6909BB5F-B2C1-44A4-B89F-7D02BA60717D_1001_1"> 328000 </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1031369" unitRef="iso4217_USD" decimals="-3" id="id_2375738_6909BB5F-B2C1-44A4-B89F-7D02BA60717D_1001_0"> 328000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1069470" unitRef="pure" decimals="INF" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_9001_4"> 0.0600 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1069470" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_9001_3"> 3244000 </us-gaap:LongTermDebt>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1073515" unitRef="pure" decimals="INF" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_10001_10"> 0.0475 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1073515" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_10001_9"> 1656000 </us-gaap:LongTermDebt>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1107489" unitRef="pure" decimals="INF" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_11001_1"> 0.0600 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1107489" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_11001_0"> 13581000 </us-gaap:LongTermDebt>
<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x961912" unitRef="pure" decimals="INF" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_12001_7"> 0.1285 </us-gaap:DebtInstrumentInterestRateStatedPercentage>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x961912" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_12001_6"> 1493000 </us-gaap:LongTermDebt>
<us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x998218" unitRef="pure" decimals="4" id="id_2375738_2A2DB385-4CF9-44AF-A3E3-44FE7B7A9FF8_2001_3"> 0.0600 </us-gaap:LongtermDebtWeightedAverageInterestRate>
<us-gaap:LongTermDebtPercentageBearingFixedInterestRate contextRef="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x998218" unitRef="pure" decimals="INF" id="id_2375738_2A2DB385-4CF9-44AF-A3E3-44FE7B7A9FF8_2001_2"> 0.0600 </us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE815564--1310-Q0008_STD_0_20120630_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_75B3E4E8-273E-4C33-81E2-5E4E26D3633E_2_1"> 100000 </us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE815564--1310-Q0008_STD_0_20120630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2001_26"> 11410000 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CommonStockSharesOutstanding contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_33"> 95573888 </us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesIssued contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_32"> 95602558 </us-gaap:CommonStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="shares" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_28"/>
<us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_26"> 50000000 </us-gaap:PreferredStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_31"> 250000000 </us-gaap:CommonStockSharesAuthorized>
<us-gaap:TreasuryStockShares contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_38"> 28670 </us-gaap:TreasuryStockShares>
<us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_30"> 0.01 </us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_25"> 0.01 </us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesIssued contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="shares" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_27"/>
<us-gaap:PreferredStockValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_24"/>
<us-gaap:AccruedLiabilitiesCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_15"> 2444000 </us-gaap:AccruedLiabilitiesCurrent>
<us-gaap:LongTermDebtNoncurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_19"> 20045000 </us-gaap:LongTermDebtNoncurrent>
<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_8"> 13006000 </us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
<us-gaap:AccountsPayableCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_14"> 3428000 </us-gaap:AccountsPayableCurrent>
<us-gaap:LiabilitiesCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_18"> 12708000 </us-gaap:LiabilitiesCurrent>
<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_36"> 2457000 </us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_39"> 35598000 </us-gaap:StockholdersEquity>
<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_34"> 268157000 </us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:DeferredRevenue contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_20"> 50000 </us-gaap:DeferredRevenue>
<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_35"> -235832000 </us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:DeferredRevenueCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_17"> 3010000 </us-gaap:DeferredRevenueCurrent>
<us-gaap:CommonStockValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_29"> 956000 </us-gaap:CommonStockValue>
<us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_40"> 68401000 </us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_6002_16"> 23871000 </us-gaap:LongTermDebt>
<us-gaap:Liabilities contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_21"> 32803000 </us-gaap:Liabilities>
<us-gaap:CommitmentsAndContingencies contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" xsi:nil="true" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_22"/>
<us-gaap:LongTermDebtCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_16"> 3826000 </us-gaap:LongTermDebtCurrent>
<us-gaap:AssetsCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_6"> 9270000 </us-gaap:AssetsCurrent>
<us-gaap:Goodwill contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_8"> 11498000 </us-gaap:Goodwill>
<us-gaap:LeaseholdImprovementsGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_6"> 88000 </us-gaap:LeaseholdImprovementsGross>
<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_9"> 23000 </us-gaap:IntangibleAssetsNetExcludingGoodwill>
<us-gaap:OtherAssetsNoncurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_10"> 1504000 </us-gaap:OtherAssetsNoncurrent>
<us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_2"> 2400000 </us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
<us-gaap:Land contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_5"> 2036000 </us-gaap:Land>
<us-gaap:Assets contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_11"> 68401000 </us-gaap:Assets>
<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_1"> 5736000 </us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:FurnitureAndFixturesGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_3"> 374000 </us-gaap:FurnitureAndFixturesGross>
<us-gaap:BuildingsAndImprovementsGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_0"> 32188000 </us-gaap:BuildingsAndImprovementsGross>
<us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_3"> 654000 </us-gaap:AccountsReceivableNetCurrent>
<us-gaap:InventoryNet contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_4"> 71000 </us-gaap:InventoryNet>
<us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_7"> 59112000 </us-gaap:PropertyPlantAndEquipmentGross>
<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_5"> 409000 </us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
<us-gaap:CapitalizedComputerSoftwareGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_2"> 2653000 </us-gaap:CapitalizedComputerSoftwareGross>
<us-gaap:ConstructionInProgressGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_4"> 91000 </us-gaap:ConstructionInProgressGross>
<us-gaap:MachineryAndEquipmentGross contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_5E1BB4A0-3909-4BCA-9768-FD7A327BF11B_2_1"> 21682000 </us-gaap:MachineryAndEquipmentGross>
<us-gaap:TreasuryStockValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_37"> 140000 </us-gaap:TreasuryStockValue>
<us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_0D7D8AD7-2EDB-4C71-A24F-61323A0621BA_2_7"> 46106000 </us-gaap:PropertyPlantAndEquipmentNet>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_926396x959606" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_7002_15"> 452000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_926396x970115" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_8002_12"> 2133000 </us-gaap:LongTermDebt>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x923434" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_1005_800001"> 2457000 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x924490" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_1006_900001"> -140000 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x929313" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_1004_700001"> -235832000 </us-gaap:StockholdersEquity>
<us-gaap:SharesIssued contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x930643" unitRef="shares" decimals="INF" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_1001_400002"> 95602558 </us-gaap:SharesIssued>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x930643" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_1001_500001"> 956000 </us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x932586" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_1003_600001"> 268157000 </us-gaap:StockholdersEquity>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_929038x923936" unitRef="shares" decimals="INF" id="id_2375738_8652DEB7-AF0D-4F69-AC75-6CA30AB1B512_2001_0"> 3254403 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_929038x923936" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_E918207F-BB05-485A-9674-06536AE8DDBA_2001_0"> 3.31 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931284x1022497" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_EF03F353-A443-4E98-B1CB-BEE6704D2988_2001_0"> 4.09 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931284x1022497" unitRef="shares" decimals="INF" id="id_2375738_A797CAC9-B14F-40C3-8662-D5E61F79623B_2001_0"> 5121807 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931284x1031369" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_DB50016A-717F-4207-A6D7-809134EC1DDC_2001_0"> 7.19 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931284x1031369" unitRef="shares" decimals="INF" id="id_2375738_AA8112E3-B667-463C-A821-C6EC6F31D4B1_2001_0"> 4258937 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x1069470" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_9002_3"> 3322000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x1073515" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_10002_9"> 1701000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x1107489" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_11002_0"> 13677000 </us-gaap:LongTermDebt>
<us-gaap:LongTermDebt contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x961912" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_12002_6"> 2586000 </us-gaap:LongTermDebt>
<us-gaap:LongtermDebtWeightedAverageInterestRate contextRef="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x998218" unitRef="pure" decimals="4" id="id_2375738_2A2DB385-4CF9-44AF-A3E3-44FE7B7A9FF8_2002_3"> 0.0600 </us-gaap:LongtermDebtWeightedAverageInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE815564--1310-Q0008_STD_211_20100127_0" unitRef="pure" decimals="2" id="id_2375738_A5F51C29-C04C-4B53-A39E-47083BBB84E6_1_0"> 0.00 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<unis:PercentageOfShareReserveAdjustment contextRef="eol_PE815564--1310-Q0008_STD_30_20091130_0" unitRef="pure" decimals="3" id="id_2375738_75EE642A-93DC-4FD1-8432-155897F89482_2_500001"> 0.175 </unis:PercentageOfShareReserveAdjustment>
<unis:LoanOfferAcceptedFromAuthority contextRef="eol_PE815564--1310-Q0008_STD_31_20091031_0_926396x955913" unitRef="iso4217_USD" decimals="-4" id="id_2375738_73C09F1D-AD87-4322-B4C6-40EF5A8DAA01_1001_0"> 5450000 </unis:LoanOfferAcceptedFromAuthority>
<invest:InvestmentOptionsExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_31_20100131_0_930809x959754" unitRef="iso4217_AUD_per_shares" decimals="INF" id="id_2375738_4666AB40-B1BC-4015-A3A9-49CCE20C2EDD_1001_1"> 6.33 </invest:InvestmentOptionsExercisePrice>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE815564--1310-Q0008_STD_31_20100131_0_930809x959754" unitRef="shares" decimals="INF" id="id_2375738_4666AB40-B1BC-4015-A3A9-49CCE20C2EDD_1_0"> 1000000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:MortgageLoansOnRealEstateNumberOfLoans contextRef="eol_PE815564--1310-Q0008_STD_31_20101031_0_931308x930693" unitRef="Note" decimals="INF" id="id_2375738_726C8897-D843-4F77-81F5-95520553680C_1_0"> 2 </us-gaap:MortgageLoansOnRealEstateNumberOfLoans>
<us-gaap:LineOfCreditFacilityFrequencyOfPayments contextRef="eol_PE815564--1310-Q0008_STD_31_20110831_0_924420x1135205" id="id_2375738_6C704CD2-1D15-4AFD-8016-775B5536F13E_1001_2"> 27 monthly installments based upon the amount drawn </us-gaap:LineOfCreditFacilityFrequencyOfPayments>
<us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="eol_PE815564--1310-Q0008_STD_31_20110831_0_924420x1135205" unitRef="pure" decimals="4" id="id_2375738_6C704CD2-1D15-4AFD-8016-775B5536F13E_1001_1"> 0.1285 </us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
<unis:LoanAmountForFinancingForLandAndConstructionOfNewManufacturingFacility contextRef="eol_PE815564--1310-Q0008_STD_31_20101231_0_926396x955913" unitRef="iso4217_USD" decimals="-4" id="id_2375738_73C09F1D-AD87-4322-B4C6-40EF5A8DAA01_1002_1"> 2250000 </unis:LoanAmountForFinancingForLandAndConstructionOfNewManufacturingFacility>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="shares" decimals="0" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_2_5"> 77250687 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="shares" xsi:nil="true" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_2_4"/>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_14"> -10462000 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_2_6"> -0.16 </us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="shares" decimals="0" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_2_3"> 77250687 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:Revenues contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_0"> 692000 </us-gaap:Revenues>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_9"> -213000 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_15"> -12324000 </us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:GrossProfit contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_2"> 633000 </us-gaap:GrossProfit>
<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_14"> 173000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
<us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_29"> 166000 </us-gaap:CapitalExpendituresIncurredButNotYetPaid>
<us-gaap:InvestmentIncomeInterest contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_10"> 24000 </us-gaap:InvestmentIncomeInterest>
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_10"> -3000 </us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<us-gaap:OperatingIncomeLoss contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_8"> -11905000 </us-gaap:OperatingIncomeLoss>
<us-gaap:RecognitionOfDeferredRevenue contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_5"> 663000 </us-gaap:RecognitionOfDeferredRevenue>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_7"> 69000 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_19"> 1173000 </us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
<us-gaap:NetIncomeLoss contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_1"> -12497000 </us-gaap:NetIncomeLoss>
<us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_8"> -5000 </us-gaap:IncreaseDecreaseInInventories>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_16"> 111000 </us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_23"> 17607000 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CostOfGoodsSold contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_1"> 59000 </us-gaap:CostOfGoodsSold>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_13"> 50000 </us-gaap:IncreaseDecreaseInDeferredRevenue>
<us-gaap:ShareBasedCompensation contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_4"> 1555000 </us-gaap:ShareBasedCompensation>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_25"> 7048000 </us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_12"> 18000 </us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:InterestExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_9"> 616000 </us-gaap:InterestExpense>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_11"> -300000 </us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_20"> 18780000 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_17"> -111000 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_4"> 4738000 </us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_3"> 1223000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_3553F63E-63C8-46EB-A252-13D5EAA92332_2_0"> 1600000 </us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:OperatingExpenses contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_7"> 12538000 </us-gaap:OperatingExpenses>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_2_5"> 6577000 </us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_2_24"> 14000 </us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_928305x923936" unitRef="shares" decimals="INF" id="id_2375738_9A5B1550-C1E9-4AE9-AFA8-C2F2F65CF816_1002_0"> 4424146 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_928305x924898" unitRef="shares" decimals="INF" id="id_2375738_5A963138-EC5B-4438-A512-C3FFB0EE3621_1002_1"> 583090 </us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_928305x924898" unitRef="shares" decimals="INF" id="id_2375738_5A963138-EC5B-4438-A512-C3FFB0EE3621_1002_0"> 10054103 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_929038x926520" unitRef="pure" decimals="4" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_2_2"> 0.0154 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_929038x926520" unitRef="pure" decimals="2" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_2_3"> 0.57 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_929038x926520" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_2_4"> P6Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_929038x926520" unitRef="pure" decimals="2" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_2_1"> 0.00 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE815564--1310-Q0008_STD_92_20120930_0_929038x926520" unitRef="shares" decimals="INF" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_2_0"> 270000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<dei:TradingSymbol contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_C46EC53F-7344-47D1-AA7E-8896EE6F07C9_1_0"> UNIS </dei:TradingSymbol>
<dei:EntityRegistrantName contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_C46EC53F-7344-47D1-AA7E-8896EE6F07C9_1_1"> Unilife Corp </dei:EntityRegistrantName>
<dei:AmendmentFlag contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_5595C2EE-27C6-41E1-BEFC-429E8D173941_1_1"> false </dei:AmendmentFlag>
<dei:EntityFilerCategory contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_C46EC53F-7344-47D1-AA7E-8896EE6F07C9_1_4"> Accelerated Filer </dei:EntityFilerCategory>
<dei:DocumentFiscalYearFocus contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_5595C2EE-27C6-41E1-BEFC-429E8D173941_1_3"> 2014 </dei:DocumentFiscalYearFocus>
<dei:DocumentType contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_5595C2EE-27C6-41E1-BEFC-429E8D173941_1_0"> 10-Q </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_5595C2EE-27C6-41E1-BEFC-429E8D173941_1_2"> 2013-09-30 </dei:DocumentPeriodEndDate>
<dei:EntityCentralIndexKey contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_C46EC53F-7344-47D1-AA7E-8896EE6F07C9_1_2"> 0001476170 </dei:EntityCentralIndexKey>
<dei:CurrentFiscalYearEndDate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_C46EC53F-7344-47D1-AA7E-8896EE6F07C9_1_3"> --06-30 </dei:CurrentFiscalYearEndDate>
<dei:DocumentFiscalPeriodFocus contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_5595C2EE-27C6-41E1-BEFC-429E8D173941_1_4"> Q1 </dei:DocumentFiscalPeriodFocus>
<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_1309E87E-6DE3-4378-B501-A96BA9A79865_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>4. Equity Transactions and Share-Based Compensation</b></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognized share-based compensation expense related to equity awards to employees, directors and consultants of $2.6 million and $1.6 million during the three months ended September 30, 2013 and 2012, respectively.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 2%; FONT-SIZE: 10pt"> <b><i>Stock Options and Warrants</i></b></p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company has granted stock options to certain employees and directors under the Employee Share Option Plan (the “Plan”). The Plan is designed to assist in the motivation and retention of employees and to recognize the importance of employees to the long-term performance and success of the Company. The Company has also granted stock options to certain consultants outside of the Plan. The majority of the options to purchase common stock vest on the anniversary of the date of grant, which ranges from one to three years. Additionally, certain stock options vest upon the closing price of the Company’s common stock reaching certain minimum levels, as defined in the agreements. Share-based compensation expense related to options granted to employees is recognized on a straight-line basis over the related vesting term. Share-based compensation expense related to options granted to consultants is recognized ratably over each vesting tranche of the options.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In November 2009, the Company adopted the 2009 Stock Incentive Plan (the “Stock Incentive Plan”). The Stock Incentive Plan initially provided for a maximum of 6,000,000 shares of common stock to be reserved for the issuance of stock options and other stock-based awards. Commencing on January 1, 2012, and on each January 1<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">st</sup> thereafter, through January 1, 2019, the share reserve automatically adjusts so that it equals 17.5% of the weighted average number of shares of common stock outstanding reduced by the sum of any shares of common stock issued under the Stock Incentive Plan and any shares of common stock subject to outstanding awards under the Stock Incentive Plan.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In January 2010, the Company issued 1,000,000 options to purchase common stock to a consultant under the Stock Incentive Plan in consideration for various services to be performed for the Company. The options to purchase common stock are exercisable at A$6.33 per share and vest upon the trading price of the Company’s CHESS Depositary Interests reaching certain minimum levels on the Australian Securities Exchange, which range from A$1.75 to A$3.22 per share. The options are re-measured each reporting date and as of September 30, 2013 were valued at $0.54 per option, which is being expensed ratably over the vesting period of each tranche, which ranges from 0.83 years to 0.98 years. The options will be re-valued on a quarterly basis and marked to market until exercised.</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <p style="MARGIN-TOP: 0pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The following is a summary of activity related to stock options held by employees and directors during three months ended September 30, 2013:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"><!-- Begin Table Head --> <tr> <td width="52%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Number of</b><br /> <b>Options</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Exercise Price</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Remaining</b><br /> <b>Contractual</b><br /> <b>Life (in years)</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Aggregate Intrinsic</b><br /> <b>Value</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center"> <b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,121,807</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.09</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Cancelled</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(74,396</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.55</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercised</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,250,000</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.85</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,797,411</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.80</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.7</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">516</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercisable as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,332,274</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">5.32</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The following is a summary of activity related to stock options and warrants held by persons other than employees and directors during the three months ended September 30, 2013:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"><!-- Begin Table Head --> <tr> <td width="53%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Number of</b><br /> <b>Options</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Exercise Price</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Remaining</b><br /> <b>Contractual</b><br /> <b>Life (in years)</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Aggregate Intrinsic</b><br /> <b>Value</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center"><b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,258,937</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.19</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Granted</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.11</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercised</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(55,000</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.85</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,503,937</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">6.98</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">328</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercisable as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,503,937</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">328</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The aggregate intrinsic value is defined as the difference between the market value of the Company’s common stock as of the end of the period and the exercise price of the in-the-money stock options. The total intrinsic value of stock options exercised during the three months ended September 30, 2013 was $1.8 million. There were no stock options exercised during the three months ended September 30, 2012.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company used the following weighted average assumptions in calculating the fair value of options granted during the three months ended September 30, 2013 and 2012:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"><!-- Begin Table Head --> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"><b>Three Months Ended<br /> September 30,</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2013</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2012</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Number of stock options granted</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">270,000</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Expected dividend yield</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Risk-free interest rate</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.54</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.54</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Expected volatility</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">57</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Expected life (in years)</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.0</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The fair value of each stock option was estimated at the grant date using the Black-Scholes option pricing model, with the exception of grants subject to market conditions, which were valued using a Monte Carlo option pricing model. The Company has not historically paid dividends to its stockholders and, as a result, assumed a dividend yield of 0%. The risk free interest rate is based upon the rates of U.S. Treasury bonds with a term equal to the expected term of the option. Due to the Company’s limited Nasdaq trading history, the expected volatility used to value options granted after January 27, 2010 is based upon a blended rate of the historical share price of the Company’s stock on the Australian Securities Exchange and the volatility of peer companies traded on U.S. exchanges operating in the same industry as the Company. The expected term of the options to purchase common stock issued to employees and directors is based upon the simplified method, which is the mid-point between the vesting date of the option and its contractual term unless a reasonable alternate term is estimated by management. The expected term of the options to purchase common stock issued to consultants is based on the contractual term of the awards.</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt">  </p> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Restricted Stock</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company has granted shares of restricted stock to certain employees and consultants under the Stock Incentive Plan. During the period prior to vesting, the holder of the non-vested restricted stock will have the right to vote and the right to receive all dividends and other distributions declared. All non-vested shares of restricted stock are reflected as outstanding; however, they have been excluded from the calculation of basic earnings per share.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> For employees, the fair value of restricted stock is measured on the date of grant using the price of the Company’s common stock on that date. Share-based compensation expense for restricted stock issued to employees is recognized on a straight-line basis over the requisite service period, which is generally the longest vesting period. For restricted stock granted to consultants, the fair value of the awards is re-valued on a quarterly basis and marked to market until vested. Share-based compensation expense for restricted stock issued to consultants is recognized ratably over each vesting tranche.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The following is a summary of activity related to restricted stock awards during the three months ended September 30, 2013:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"><!-- Begin Table Head --> <tr> <td width="58%"></td> <td valign="bottom" width="15%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="15%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"> <b>Number of Restricted</b><br /> <b>Stock Awards</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted Average</b><br /> <b>Grant Date Fair Value</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Unvested as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,254,403</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.31</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Granted</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.38</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Vested</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(402,750</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.25</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Cancelled</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,500</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.46</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Unvested as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,902,153</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.32</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> </tr> </table> </div>
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_F01D41F6-C384-4DDB-8E82-284EA8571A63_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (“ASU 2013-02”). The new guidance requires an entity to disclose in a single location the effects of reclassifications out of accumulated other comprehensive income (“AOCI”). For items reclassified out of AOCI and into net income in their entirety, entities must disclose the effect of the reclassification on each affected net income item. For AOCI reclassification items that are not reclassified in their entirety into net income, entities must provide a cross reference to other required U.S. GAAP disclosures. The standard does not change the items which must be reported in other comprehensive income. ASU 2013-02 is effective for annual and interim periods for fiscal years beginning after December 15, 2012. Since this guidance impacts presentation only, it has had no effect on the Company’s financial condition or its financial statements.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In July 2013, the FASB issued ASC 2013-11, “Income Taxes — Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists<i>”</i> (“ASU 2013-11”) which is part of Accounting Standards Codification (“ASC”) 740: Income Taxes. The new guidance requires an entity to present an unrecognized tax benefit and an NOL carryforward, a similar tax loss, or a tax credit carryforward on a net basis as part of a deferred tax asset, unless the unrecognized tax benefit is not available to reduce the deferred tax asset component or would not be utilized for that purpose, then a liability would be recognized. ASU 2013-11 is effective for annual and interim periods for fiscal years beginning after December 15, 2013. The Company is currently evaluating the impact of the July 1, 2014 adoption of this guidance on its financial statements.</p> </div>
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
<us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_625BDE19-465E-4312-AFBF-4253837C3A52_1_0">
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>6. Goodwill and Intangible Assets</b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The changes in the carrying amount of goodwill during the three months ended September 30, 2013 are as follows:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">  </p> <table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"> <tr> <td width="84%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family:Times New Roman; font-size:8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> <b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="font-family:Times New Roman; font-size:10pt"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"> Balance as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,498</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-family:Times New Roman; font-size:10pt"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"> Foreign currency translation</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">214</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="border-top:1.00px solid #000000"> </p> </td> <td valign="bottom"> <p style="border-top:1.00px solid #000000"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="font-family:Times New Roman; font-size:10pt"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"> Balance as of September 30, 2013</p> </td> <td valign="bottom"><font style="font-size:8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,712</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="border-top:3.00px double #000000"> </p> </td> <td valign="bottom"> <p style="border-top:3.00px double #000000"> </p> </td> <td> </td> </tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> Intangible assets consist of patents acquired in a business acquisition of $0.1 million. Related accumulated amortization as of both September 30, 2013 and June 30, 2012 was $0.1 million. Future amortization expense is scheduled to be $7,000 annually, excluding the impact of foreign currency exchange.</p> </div>
</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_B221591A-DE97-422B-BFC6-733BE2A97767_1_0">
<div> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>9. Contingencies</b></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> From time to time, the Company is involved in various legal proceedings, claims, suits and complaints arising out of the normal course of business. Based on the facts currently available to the Company, management believes that these claims, suits and complaints are adequately provided for, covered by insurance, without merit or not probable that an unfavorable outcome will result.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> As previously disclosed, on September 7, 2012, the Company received a letter from counsel for Talbot (Todd) Smith, a former employee, alleging that Mr. Smith was wrongly terminated. Mr. Smith, who was terminated “for cause” by the Company, filed a complaint with the Occupational Safety & Health Administration (“OSHA”) in November 2012. The Company and various third parties have investigated the allegations made by Mr. Smith and have determined that the allegations are without merit. The Company believes the allegations made by Mr. Smith against the Company are in retaliation for his “for cause” termination and has been defending itself vigorously in the OSHA matter. Because OSHA did not make a final determination on Mr. Smith’s complaint within 180 days, Mr. Smith filed a complaint with the U.S. District Court for the Eastern District of Pennsylvania (“USDC”) on August 30, 2013. The USDC complaint makes the same allegations made by Mr. Smith in the OSHA complaint and does not make any additional material allegations. Given that the allegations made by Mr. Smith in the USDC complaint are nearly identical to those made in his OSHA complaint, the Company and various third parties have investigated the allegations previously and have determined that the allegations are without merit, and the Company will defend itself vigorously in court. Given that Mr. Smith has now filed the complaint with the USDC, OSHA has dismissed the OSHA matter without a final determination.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> As previously disclosed, subsequent to the filing of the OSHA complaint by Mr. Smith on February 12, 2013, the Company received a subpoena from the staff of the U.S. Securities and Exchange Commission (the “Staff”) requesting the Company to provide certain information to the Staff, which is generally consistent with the meritless allegations made by Mr. Smith in his OSHA complaint. In the USDC complaint, Mr. Smith states that he provided the Staff with information about his allegations in July and August 2012. The Company responded to that subpoena and received a second subpoena from the Staff, requesting additional information consistent with the first subpoena. The Company is cooperating fully with the Staff and has provided the requested information.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> On November 1, 2013, the Company and certain of its officers were named as defendants in a purported class action lawsuit filed in the United States District Court for the Middle District of Pennsylvania alleging violations of the federal securities laws. The lawsuit was brought on behalf of a purported stockholder of the Company and all other similarly situated stockholders who purchased the Company’s securities between July 13, 2011 and September 9, 2013 (the “Class Period”). The complaint appears to be mainly based on the meritless allegations made by Mr. Smith in his complaint and generally alleges that the defendants made false and misleading statements regarding the Company’s business, operations and prospects, which allegedly caused the plaintiff and other members of the purported class to purchase the Company’s securities at inflated prices during the Class Period. The lawsuit seeks unspecified damages. With respect to the allegations made in these claims, the Company believes it is in full compliance with all applicable regulatory requirements. In 2013 two regulatory compliance audits of the Company’s quality system were performed. Both audits resulted in zero observations, i.e.,no deviations from applicable quality standards were noted. In February 2013, the Notified Body NSAI (National Standards Authority of Ireland) performed an audit of the quality system, which is equivalent to an FDA audit for European countries. This audit resulted in zero observations, i.e., no deviations from the applicable standards were found. The auditor’s conclusion was that the Company was in compliance with the applicable standards. In March, 2013, the FDA performed an audit of the Company’s quality system and facility. The FDA closed out the audit with no FDA 483 Inspectional Observation issued, i.e., no deviations from the applicable standards were noted. The Company intends to vigorously defend this matter and believes that the allegations are without merit.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company does not believe there will be any material impact to the Company or its business as a result of these matters.</p> <!-- xbrl,n --> </div>
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_D36B7D43-DDE6-430F-843C-2C26BEBA2679_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Revenue Recognition</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes revenue from industrialization and development fees, licensing fees and product sales.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes up front, non-refundable fees ratably over the expected life of the related agreement. Revenue from industrialization and development fees is recognized upon achievement of the “at risk” milestone events, which represent the culmination of the earnings process related to such events. Milestones can include specific phases of projects such as product design, prototype availability, user tests, manufacturing proof of principle and the various steps to complete the industrialization of the product. Revenue is recognized when each substantive milestone has been achieved and the Company has no future performance obligations related to the milestone.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes revenue from sales of products at the time of shipment when title passes to the customer.</p> </div>
</us-gaap:RevenueRecognitionPolicyTextBlock>
<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="shares" decimals="0" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_1_5"> 93833603 </us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_50205189-9D84-4AB4-9011-5176FCFF36CA_1_0">
<div> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Property, plant and equipment consist of the following:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"><!-- Begin Table Head --> <tr> <td width="74%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>September 30,</b><br /> <b>2013</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>June 30,</b><br /> <b>2013</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"><b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Building</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,188</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,188</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Machinery and equipment</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">18,363</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,682</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Computer software</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,653</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,653</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Furniture and fixtures</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">556</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">374</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Construction in progress</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">272</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">91</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Land</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,036</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,036</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Leasehold improvements</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">166</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">88</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">56,234</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">59,112</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Less: accumulated depreciation and amortization</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">(10,510</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">(13,006</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Property, plant and equipment, net</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">45,724</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">46,106</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <!-- xbrl,n --> </div>
</us-gaap:PropertyPlantAndEquipmentTextBlock>
<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_FBF26B6D-39D0-4798-9749-3DE6ACD33A4D_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>5. Property, Plant and Equipment and Construction-in-Progress</b></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Property, plant and equipment consist of the following:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"><!-- Begin Table Head --> <tr> <td width="74%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>September 30,</b><br /> <b>2013</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>June 30,</b><br /> <b>2013</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"><b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Building</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,188</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">32,188</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Machinery and equipment</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">18,363</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,682</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Computer software</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,653</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,653</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Furniture and fixtures</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">556</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">374</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Construction in progress</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">272</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">91</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Land</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,036</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,036</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Leasehold improvements</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">166</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">88</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">56,234</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">59,112</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Less: accumulated depreciation and amortization</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">(10,510</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">(13,006</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Property, plant and equipment, net</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">45,724</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">46,106</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <!-- xbrl,n --> </div>
</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_D8000CE0-E6A1-45D6-AC06-823193BE34A3_1_0">
<div> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Principles of Consolidation</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The consolidated financial statements include the accounts of Unilife Corporation and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</p> </div>
</us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_AD7F2D2C-2F7C-4E00-87AE-75DA7AA22F82_1_0">
<div> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company’s net loss per share is as follows:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="72%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended<br /> September 30,</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2013</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2012</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt" align="center"> <b>(In thousands, except share and per</b></p> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt" align="center"><b>share data)</b></p> </td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> <b>Numerator</b></p> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Net loss</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,244</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(12,497</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> <b>Denominator</b></p> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Weighted average number of shares used to compute basic net loss per share</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">93,833,603</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">77,250,687</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Effect of dilutive options to purchase common stock</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Weighted average number of shares used to compute diluted net loss per share</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">93,833,603</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">77,250,687</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> <b>Basic and diluted net loss per share</b></p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.12</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.16</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div>
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="shares" xsi:nil="true" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_1_4"/>
<us-gaap:LongTermDebtTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_574EEC12-430A-491C-9D99-81DCCC9BE682_1_0">
<div> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>7. Long-Term Debt</b></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Long-term debt consists of the following:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"><!-- Begin Table Head --> <tr> <td width="68%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>September 30, 2013</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>June 30, 2013</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"><b>(In thousands)</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 6.00% Mortgage loan, due December 2031</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,581</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,677</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 6.00% Mortgage loan, due October 2020</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,244</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,322</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 12.85% Secured lending facility, due 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,493</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,586</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 4.75% Bank term loans, due January 2021 through August 2021</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,656</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,701</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 5.00% Commonwealth of Pennsylvania financing authority loan, due January 2021</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,121</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,133</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Other</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">376</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">452</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">22,471</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">23,871</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Less: current portion of long-term debt</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,719</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,826</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Total long-term debt</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,752</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">20,045</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 2%; FONT-SIZE: 10pt"> <b><i><u>Mortgage Loans</u></i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In October 2010, Unilife Cross Farm LLC, a wholly owned subsidiary of the Company, (“Cross Farm”) entered into a loan agreement with Metro Bank (“Metro”), pursuant to which Metro provided Cross Farm with two mortgage loans in the amounts of $14.25 million and $3.75 million. The proceeds received were used to finance the purchase of land and construction of the Company’s corporate headquarters and manufacturing facility in York, Pennsylvania.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> During construction, Cross Farm paid only interest on both term loans at the Prime Rate plus 1.50% per annum, with a floor of 4.50% per annum. Subsequent to construction, Cross Farm is paying principal and interest on both term loans, with interest at a fixed rate of 6.00%. The weighted average interest rate on both term notes was 6.00% during the three months ended September 30, 2013 and year ended June 30, 2013.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The loan agreement contains certain customary covenants, including the maintenance of a Debt Service Reserve Account in the amount of $2.4 million, classified as restricted cash on the consolidated balance sheet, which will remain in place until Cross Farm and Metro agree on the financial covenants. The terms of the loan agreement allow the Company to use the Debt Service Reserve Account to pay monthly debt service on the mortgage loans, so long as the balance in the account is at least $1.6 million and is replenished to $2.4 million every six months. The Company was in compliance with its debt covenants as of September 30, 2013. However, there can be no assurance that the Company will be able to maintain the Debt Service Reserve Account balance for a period of 12 months from September 30, 2013. Cross Farm may prepay the loan without penalty. The U.S. Department of Agriculture has guaranteed $10.0 million of the loans.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 2%; FONT-SIZE: 10pt"> <b><i><u>Secured Lending Facility</u></i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In August 2011, the Company entered into a Master Lease Agreement (the “Lease Agreement”) with Varilease Finance, Inc. (“Varilease”) for up to $10.0 million of secured financing for production equipment for its Unifill syringe. Based on the Company’s continuing involvement throughout the term of the agreement and the integral nature of the production equipment, the transaction is being accounted for as a financing. Over the term of the Lease Agreement, the Company will make up to 27 monthly installments based upon the amount drawn. This facility has an effective interest rate of 12.85%. The secured lending facility contains covenants and provisions for events of default customarily found in lease agreements.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> As previously disclosed, on September 30, 2013, Varilease and CCA Financial LLC filed an action in the State of Michigan in the Circuit Court for the County of Oakland, Case No. 2013-136458-CK seeking a judgment confirming the terms of the lease. The Company removed the action to the U.S. District Court for the Eastern District of Michigan, Case No. 2:13-CV-14238-SFC-LJM, on October 4, 2013. Under the Lease Agreement, Varilease and the Company were to negotiate a buyout rate at the end of the two-year lease term, which Varilease represented to the Company during the lease negotiations would be 15% of the amount financed. When the Company notified Varilease that it wanted to exercise the buyout of the equipment, Varilease claimed a buyout rate significantly higher than 15%. Under the terms of the lease, if the parties are unable to agree on a buyout rate by the end of the lease term, the lease will automatically renew for an additional 12-month period and the Company would be responsible for another year of lease payments. Varilease’s action in Michigan state court asked the court to confirm that the parties have been unable to agree on a buyout rate and therefore under the terms of the lease the lease is automatically extended for one year.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company also filed suit on September 30, 2013 against Varilease and CCA Financial in the U.S. District Court for the Eastern District of Michigan, Case No. 2:13-cv-14174-SFC-LJM alleging, among other things, that Varilease fraudulently induced the Company into entering the lease by making misrepresentations about the buyout rate. The Company seeks, among things, to have the federal court enforce a 15% buyout rate and to enjoin Varilease from declaring a default under the lease and taking possession of the equipment for which the company would have to impair the carrying value of assets. On October 17, 2013, in a stipulated order, the U.S. District Court ordered that the Company continue to make the same monthly payments under the lease, that as long as the Company makes timely payments, Varilease shall not declare a default, and that Varilease is required to provide advance notice of a default. A conference has been scheduled to take place on November 25, 2013. While the Company intends to vigorously pursue its claims and defend itself in the actions described above, it is not possible to determine the outcome of these matters.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 2%; FONT-SIZE: 10pt"> <b><i><u>Commonwealth of Pennsylvania Financing Authority Loan</u></i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In October 2009, the Company accepted a $5.45 million offer of assistance from the Commonwealth of Pennsylvania which included up to $2.25 million in financing for land and the construction of its current manufacturing facility. In December 2010, Cross Farm received the $2.25 million loan which bears interest at a rate of 5.00% per annum, matures in January 2021 and is secured by a third mortgage on the facility. In connection with the loan agreement, Cross Farm entered into an intercreditor agreement by which the Commonwealth of Pennsylvania agreed that it would not exercise its rights in the event of a default by Cross Farm without the consent of Metro, which holds the first and second mortgages on the facility.</p> <!-- xbrl,n --> </div>
</us-gaap:LongTermDebtTextBlock>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_C3EDCAFB-7CB1-4962-B0F7-07308047D417_1_2"> 0.54 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<us-gaap:InventoryPolicyTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_41B8C8D4-D63E-4B06-920B-C672EA439434_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Inventories</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Inventories consist primarily of syringe components and include direct materials, direct labor and manufacturing overhead. Inventories are stated at the lower of cost or market, with cost determined using the first in, first out method. The Company routinely reviews its inventory for obsolete, slow moving or otherwise impaired inventory and records estimated impairments in the periods in which they occur.</p> </div>
</us-gaap:InventoryPolicyTextBlock>
<us-gaap:ScheduleOfGoodwillTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_83E2DCCD-4913-484E-A748-FC808DC2F459_1_0">
<div> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The changes in the carrying amount of goodwill during the three months ended September 30, 2013 are as follows:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">  </p> <table cellspacing="0" cellpadding="0" width="68%" border="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" align="center"> <tr> <td width="84%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="font-family:Times New Roman; font-size:8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1.00pt solid #000000"> <b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF" style="font-family:Times New Roman; font-size:10pt"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"> Balance as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,498</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-family:Times New Roman; font-size:10pt"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"> Foreign currency translation</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">214</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="border-top:1.00px solid #000000"> </p> </td> <td valign="bottom"> <p style="border-top:1.00px solid #000000"> </p> </td> <td> </td> </tr> <tr bgcolor="#CCEEFF" style="font-family:Times New Roman; font-size:10pt"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"> Balance as of September 30, 2013</p> </td> <td valign="bottom"><font style="font-size:8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">11,712</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px;"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="border-top:3.00px double #000000"> </p> </td> <td valign="bottom"> <p style="border-top:3.00px double #000000"> </p> </td> <td> </td> </tr> </table> </div>
</us-gaap:ScheduleOfGoodwillTextBlock>
<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_14"> -9414000 </us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:EarningsPerShareBasicAndDiluted contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_1_6"> -0.12 </us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_6B2837EF-991A-4C74-BC54-E2452C22C83E_1_0">
<div> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The following is a summary of activity related to restricted stock awards during the three months ended September 30, 2013:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="58%"></td> <td valign="bottom" width="15%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="15%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"> <b>Number of Restricted</b><br /> <b>Stock Awards</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted Average</b><br /> <b>Grant Date Fair Value</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Unvested as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,254,403</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.31</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Granted</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.38</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Vested</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(402,750</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.25</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Cancelled</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,500</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.46</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Unvested as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,902,153</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.32</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div>
</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_DA7DC99D-B005-4F09-A93C-4B166FCF9CBA_1_0">
<div> <p style="MARGIN-TOP: 12pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>1. Description of Business and Unaudited Financial Statements</b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Unilife Corporation and subsidiaries (the “Company”) is a U.S. based manufacturer and supplier of injectable drug delivery systems. The Company’s customers are biotechnology companies who seek to leverage its innovative, differentiated and customizable devices to enable or enhance the clinical development, regulatory approval and commercial lifecycles of its injectable biologics, drugs and vaccines. The Company manufactures and supplies its proprietary devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user for safe, simple and convenient administration.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The accompanying unaudited consolidated financial statements contain all normal and recurring adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented as required by Rule 10-01 of Regulation S-X. Interim results may not be indicative of results for a full year. The accompanying unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the fiscal year ended June 30, 2013 contained in its Annual Report on Form 10-K.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> References to A$ mean the lawful currency of the Commonwealth of Australia. References to € or euros are to the lawful currency of the European Union.</p> </div>
</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="shares" decimals="0" id="id_2375738_CCF599D9-986F-45FD-8BC7-922876F5A8E5_1_3"> 93833603 </us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
<us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_4BC0E6D5-ED0A-41FC-B8EE-268BB02B4465_1_0">
<div> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Long-term debt consists of the following:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="68%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>September 30, 2013</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>June 30, 2013</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"><b>(In thousands)</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 6.00% Mortgage loan, due December 2031</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,581</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,677</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 6.00% Mortgage loan, due October 2020</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,244</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,322</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 12.85% Secured lending facility, due 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,493</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,586</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 4.75% Bank term loans, due January 2021 through August 2021</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,656</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,701</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> 5.00% Commonwealth of Pennsylvania financing authority loan, due January 2021</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,121</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,133</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Other</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">376</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">452</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">22,471</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">23,871</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Less: current portion of long-term debt</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,719</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,826</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Total long-term debt</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">19,752</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">20,045</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div>
</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
<us-gaap:EarningsPerShareTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_F3C39EAA-5F2D-4925-AFFE-D692EEF62AC7_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>8. Net Loss Per Share</b></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company’s net loss per share is as follows:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"><!-- Begin Table Head --> <tr> <td width="72%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center"><b>Three Months Ended<br /> September 30,</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2013</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2012</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt" align="center"> <b>(In thousands, except share and per</b></p> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt" align="center"><b>share data)</b></p> </td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> <b>Numerator</b></p> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Net loss</p> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(11,244</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(12,497</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> <b>Denominator</b></p> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Weighted average number of shares used to compute basic net loss per share</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">93,833,603</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">77,250,687</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Effect of dilutive options to purchase common stock</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Weighted average number of shares used to compute diluted net loss per share</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">93,833,603</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">77,250,687</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> <b>Basic and diluted net loss per share</b></p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.12</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.16</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <!-- End Table Body --></table> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Due to the Company’s net losses, unvested shares of restricted stock (participating securities) totaling 3,147,851 and 4,424,146 were excluded from the calculation of basic and diluted net loss per share during the three months ended September 30, 2013 and 2012, respectively.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In addition, stock options (non-participating securities) totaling 6,283,164 and 10,054,103 during the three months ended September 30, 2013 and 2012, respectively, were excluded from the calculation of diluted net loss per share as their effect would have been anti-dilutive. Certain of these stock options were excluded solely due to the Company’s net loss position. Had the Company reported net income during the three months ended September 30, 2013 and 2012, these shares would have had an effect of 495,572 and 583,090 diluted shares, respectively, for purposes of calculating diluted net loss per share.</p> </div>
</us-gaap:EarningsPerShareTextBlock>
<us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_447E87E6-EA48-4A82-B137-793463967496_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Reclassifications</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Certain prior year amounts in the consolidated financial statements have been reclassified to conform to the current year presentation.</p> </div>
</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
<us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_7B552E30-47A2-41FA-814E-B999099DAD02_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Share-Based Compensation</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company grants equity awards to its employees, directors and consultants. Certain employee and director awards vest over stated vesting periods and others also require achievement of specific performance or market conditions. The Company expenses the grant-date fair value of awards to employees and directors over their respective vesting periods. To the extent that employee and director awards vest only upon the achievement of a specific performance condition, expense is recognized over the period from the date management determines that the performance condition is probable of achievement through the date they are expected to be met. Awards granted to consultants are sometimes granted for past services, in which case their fair value is expensed on their grant date, while other awards require future service, or the achievement of performance or market conditions. Timing of expense recognition for consultant awards is similar to that of employee and director awards; however, aggregate expense is re-measured each quarter-end based on the then fair value of the award through the vesting date of the award. The Company estimates the fair value of stock options using the Black-Scholes option-pricing model, with the exception of market-based grants, which are valued based on the Monte Carlo option pricing model. Option pricing methods require the input of highly subjective assumptions, including the expected stock price volatility.</p> </div>
</us-gaap:CompensationRelatedCostsPolicyTextBlock>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_ACF9DF04-D9BE-48EE-99C6-122582778BC7_1_0">
<div> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>3. Summary of Significant Accounting Policies</b></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Principles of Consolidation</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The consolidated financial statements include the accounts of Unilife Corporation and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The estimates are principally in the areas of revenue recognition and share-based compensation expense. Management bases its estimates on historical experience and various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Inventories</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Inventories consist primarily of syringe components and include direct materials, direct labor and manufacturing overhead. Inventories are stated at the lower of cost or market, with cost determined using the first in, first out method. The Company routinely reviews its inventory for obsolete, slow moving or otherwise impaired inventory and records estimated impairments in the periods in which they occur.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Share-Based Compensation</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company grants equity awards to its employees, directors and consultants. Certain employee and director awards vest over stated vesting periods and others also require achievement of specific performance or market conditions. The Company expenses the grant-date fair value of awards to employees and directors over their respective vesting periods. To the extent that employee and director awards vest only upon the achievement of a specific performance condition, expense is recognized over the period from the date management determines that the performance condition is probable of achievement through the date they are expected to be met. Awards granted to consultants are sometimes granted for past services, in which case their fair value is expensed on their grant date, while other awards require future service, or the achievement of performance or market conditions. Timing of expense recognition for consultant awards is similar to that of employee and director awards; however, aggregate expense is re-measured each quarter-end based on the then fair value of the award through the vesting date of the award. The Company estimates the fair value of stock options using the Black-Scholes option-pricing model, with the exception of market-based grants, which are valued based on the Monte Carlo option pricing model. Option pricing methods require the input of highly subjective assumptions, including the expected stock price volatility.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Revenue Recognition</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes revenue from industrialization and development fees, licensing fees and product sales.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes up front, non-refundable fees ratably over the expected life of the related agreement. Revenue from industrialization and development fees is recognized upon achievement of the “at risk” milestone events, which represent the culmination of the earnings process related to such events. Milestones can include specific phases of projects such as product design, prototype availability, user tests, manufacturing proof of principle and the various steps to complete the industrialization of the product. Revenue is recognized when each substantive milestone has been achieved and the Company has no future performance obligations related to the milestone.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company recognizes revenue from sales of products at the time of shipment when title passes to the customer.</p> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Reclassifications</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Certain prior year amounts in the consolidated financial statements have been reclassified to conform to the current year presentation.</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 18pt">  </p> <p style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (“ASU 2013-02”). The new guidance requires an entity to disclose in a single location the effects of reclassifications out of accumulated other comprehensive income (“AOCI”). For items reclassified out of AOCI and into net income in their entirety, entities must disclose the effect of the reclassification on each affected net income item. For AOCI reclassification items that are not reclassified in their entirety into net income, entities must provide a cross reference to other required U.S. GAAP disclosures. The standard does not change the items which must be reported in other comprehensive income. ASU 2013-02 is effective for annual and interim periods for fiscal years beginning after December 15, 2012. Since this guidance impacts presentation only, it has had no effect on the Company’s financial condition or its financial statements.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In July 2013, the FASB issued ASC 2013-11, “Income Taxes — Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists<i>”</i> (“ASU 2013-11”) which is part of Accounting Standards Codification (“ASC”) 740: Income Taxes. The new guidance requires an entity to present an unrecognized tax benefit and an NOL carryforward, a similar tax loss, or a tax credit carryforward on a net basis as part of a deferred tax asset, unless the unrecognized tax benefit is not available to reduce the deferred tax asset component or would not be utilized for that purpose, then a liability would be recognized. ASU 2013-11 is effective for annual and interim periods for fiscal years beginning after December 15, 2013. The Company is currently evaluating the impact of the July 1, 2014 adoption of this guidance on its financial statements.</p> <!-- xbrl,n --> </div>
</us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:UseOfEstimates contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_FB85A6EC-109C-405A-83BC-E73A74570F10_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The estimates are principally in the areas of revenue recognition and share-based compensation expense. Management bases its estimates on historical experience and various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p> </div>
</us-gaap:UseOfEstimates>
<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_89E058F8-AF2F-4899-A13E-159655DD20A3_1_0">
<div> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company used the following weighted average assumptions in calculating the fair value of options granted during the three months ended September 30, 2013 and 2012:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"><b>Three Months Ended<br /> September 30,</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2013</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>2012</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Number of stock options granted</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">270,000</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Expected dividend yield</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Risk-free interest rate</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.54</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.54</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Expected volatility</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55</td> <td valign="bottom" nowrap="nowrap">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">57</td> <td valign="bottom" nowrap="nowrap">% </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Expected life (in years)</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6.0</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> </div>
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="shares" decimals="INF" id="id_2375738_97F09641-9240-4BA2-92E4-B835EBE32117_2_1"> 3512153 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:Revenues contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_0"> 3187000 </us-gaap:Revenues>
<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_9"> -124000 </us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
<us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_15"> -10983000 </us-gaap:ComprehensiveIncomeNetOfTax>
<us-gaap:GrossProfit contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_2"> 3187000 </us-gaap:GrossProfit>
<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5007_1000004"> 261000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
<us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_29"> 229000 </us-gaap:CapitalExpendituresIncurredButNotYetPaid>
<us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_11"> 4000 </us-gaap:OtherNonoperatingIncomeExpense>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5007_1000009"> 2234000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:InvestmentIncomeInterest contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_10"> 6000 </us-gaap:InvestmentIncomeInterest>
<us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_10"> -6000 </us-gaap:IncreaseDecreaseInOtherOperatingAssets>
<us-gaap:OperatingIncomeLoss contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_8"> -10774000 </us-gaap:OperatingIncomeLoss>
<us-gaap:RecognitionOfDeferredRevenue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_5"> 3187000 </us-gaap:RecognitionOfDeferredRevenue>
<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_7"> -935000 </us-gaap:IncreaseDecreaseInAccountsReceivable>
<us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_19"> 1108000 </us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
<us-gaap:NetIncomeLoss contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5007_1000003"> -11244000 </us-gaap:NetIncomeLoss>
<us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_8"> 1000 </us-gaap:IncreaseDecreaseInInventories>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5007_1000005"> 2636000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5007_1000007"> 10668000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_16"> 1166000 </us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
<us-gaap:IncreaseDecreaseInRestrictedCash contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_22"> -434000 </us-gaap:IncreaseDecreaseInRestrictedCash>
<us-gaap:FinitelivedIntangibleAssetsAcquired1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_75B3E4E8-273E-4C33-81E2-5E4E26D3633E_1_0"> 100000 </us-gaap:FinitelivedIntangibleAssetsAcquired1>
<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_23"> 12228000 </us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" xsi:nil="true" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_13"/>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_30468FFA-8D29-436F-9CB0-F5C04EBFDDEA_1_0"> 1800000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
<us-gaap:ShareBasedCompensation contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_4"> 2636000 </us-gaap:ShareBasedCompensation>
<us-gaap:GoodwillTranslationAdjustments contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_30248B14-930E-4B8D-82A2-02293716C3D5_5001_2"> 214000 </us-gaap:GoodwillTranslationAdjustments>
<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_25"> 1680000 </us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_12"> 980000 </us-gaap:IncreaseDecreaseInAccruedLiabilities>
<us-gaap:InterestExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_9"> 480000 </us-gaap:InterestExpense>
<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_11"> -705000 </us-gaap:IncreaseDecreaseInAccountsPayable>
<us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_20"> 10668000 </us-gaap:ProceedsFromIssuanceOfCommonStock>
<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_17"> -1166000 </us-gaap:NetCashProvidedByUsedInInvestingActivities>
<us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_4"> 6399000 </us-gaap:ResearchAndDevelopmentExpense>
<us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_21"> 2234000 </us-gaap:ProceedsFromStockOptionsExercised>
<us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_3"> 1042000 </us-gaap:DepreciationDepletionAndAmortization>
<us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-5" id="id_2375738_3553F63E-63C8-46EB-A252-13D5EAA92332_1_0"> 2600000 </us-gaap:AllocatedShareBasedCompensationExpense>
<us-gaap:OperatingExpenses contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_7"> 13961000 </us-gaap:OperatingExpenses>
<us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_E1313981-4DE7-4EDF-9C3E-076B19ADD962_1_5"> 6520000 </us-gaap:SellingGeneralAndAdministrativeExpense>
<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="iso4217_USD" decimals="-3" id="id_2375738_3DD334AB-91D8-436B-894B-11FAF55AF145_1_24"> 32000 </us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
<unis:AdditionalLeasePeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_8F92B8CC-A7B2-4ECB-86A9-F596B2BD4DE4_1_2"> P1Y </unis:AdditionalLeasePeriod>
<unis:TermOfLeasePeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_8F92B8CC-A7B2-4ECB-86A9-F596B2BD4DE4_1_1"> P2Y </unis:TermOfLeasePeriod>
<unis:ScheduleOfShareBasedCompensationStockOptionsActivityByNonEmployeesAndNonDirectorsTableTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_072DE21A-B6FC-466A-9ACD-5D2FAA7DC092_1_0">
<div> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The following is a summary of activity related to stock options and warrants held by persons other than employees and directors during the three months ended September 30, 2013:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="53%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Number of</b><br /> <b>Options</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Exercise Price</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Remaining</b><br /> <b>Contractual</b><br /> <b>Life (in years)</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Aggregate Intrinsic</b><br /> <b>Value</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center"><b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,258,937</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.19</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Granted</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3.11</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercised</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(55,000</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.85</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,503,937</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">6.98</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">328</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercisable as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,503,937</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">7.30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">328</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div>
</unis:ScheduleOfShareBasedCompensationStockOptionsActivityByNonEmployeesAndNonDirectorsTableTextBlock>
<unis:BusinessAlliancesDisclosureTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_5251E3B3-E54C-4554-9029-2BED6F9DC444_1_0">
<div> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> <b>10. Business Alliances</b></p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"> <b><i>Sanofi</i></b></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The Company signed an exclusivity agreement and an industrialization agreement with Sanofi, a multinational pharmaceutical company, between June 2008 and July 2009. Under the terms of these agreements, Sanofi had agreed to pay the Company an aggregate of approximately $36.4 million in exclusivity fees and industrialization milestone payments for the exclusive right to negotiate the purchase of the Unifill ready-to-fill (prefilled) syringe (Unifill syringe or product) which was developed pursuant to the agreements. Sanofi had paid the Company a €10.0 million ($13.0 million) up front non-refundable one-time fee which the Company was recognizing as revenue over the expected term of the agreement.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> On September 3, 2013, the Company and Sanofi entered into a supply agreement and terminated both the exclusivity agreement and the industrialization agreement. As a result, the Company has recognized the remaining unamortized revenue of $2.3 million during the three months ended September 30, 2013. Under the terms of the supply agreement, the Company has granted Sanofi the exclusive use of the Unifill Finesse with anti-thrombotic drugs during the contract period. Following a four year ramp-up period after market entry, exclusivity will be maintained, subject to Sanofi purchasing a minimum of 150 million units of the Unifill Finesse or other Unifill syringes per year. The Company can supply its Unifill syringes, including the Unifill Finesse, to additional customers in all other therapeutic classes outside of anti-thrombotics. In addition to future revenue from the sale of Unifill Finesse syringes, the Company may receive up to $15 million from Sanofi in milestone-based payments with $5.0 million of these payments received in October 2013. This supply contract replaces and supersedes all other agreements previously signed between both parties regarding the Unifill syringe platform.</p> </div>
</unis:BusinessAlliancesDisclosureTextBlock>
<unis:LiquidityTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_DDB3F060-22C3-484E-B2F2-A3F3CB067BA9_1_0">
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>2. Liquidity</b></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company has incurred recurring losses from operations during the year ended June 30, 2013, and the three months ended September 30, 2013, and anticipates incurring additional losses until such time that it can generate sufficient revenue from the sale, customization, or exclusive use and licensing of its proprietary range of injectable drug delivery systems to pharmaceutical and biotechnology customers. Management has taken such steps delineated below to address its cash requirements.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company needs additional funding to support its operations and capital expenditure requirements. The Company continues to have discussions with current and prospective customers for many active programs in its commercial pipeline and expects to progressively execute agreements featuring a combination of revenue streams including exclusivity fees, device customization programs and supply contracts that are expected to generate cash payments to the Company during calendar 2014. Given the substantial size, complexity and long-term duration of many of these prospective agreements, some can take a significant time to negotiate and finalize. The Company is consciously managing its cash position to minimize raising additional equity capital and thereby minimize dilution to existing stockholders.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The Company continues to evaluate debt funding programs available to the Company as part of its overall financing strategy. Combined with the ancipated revenue to be generated from new and existing customer agreements or through other transactions, the Company expects to have sufficient near term liquidity. However, there can be no assurance that such additional funding, or sales transactions, will close as expected or be available when needed. These various factors continue to raise substantial doubt about the Company’s ability to continue as a going concern.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> In October 2012, the Company entered into a Controlled Equity Offering Sales Agreement, (the “Sales Agreement”) pursuant to which the Company may, from time to time, issue and sell shares of common stock having an aggregate offering price of up to $45.0 million. During the three months ended September 30, 2013, the Company issued 3,512,153 shares of common stock and raised approximately $10.7 million under the Sales Agreement. The Company is not obligated to make any additional sales of shares under the Sales Agreement. As of September 30, 2013, there was approximately $19.2 million available under the Sales Agreement.</p> </div>
</unis:LiquidityTextBlock>
<unis:ScheduleOfShareBasedCompensationStockOptionsActivityByEmployeesAndDirectorsTableTextBlock contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" id="id_2375738_4DFB5D9C-A3D1-4145-AEE7-494C6CD5EDF6_1_0">
<div> <p style="MARGIN-TOP: 0pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The following is a summary of activity related to stock options held by employees and directors during three months ended September 30, 2013:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt">  </p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"><!-- Begin Table Head --> <tr> <td width="52%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Number of</b><br /> <b>Options</b></td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Exercise Price</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Weighted</b><br /> <b>Average</b><br /> <b>Remaining</b><br /> <b>Contractual</b><br /> <b>Life (in years)</b></td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"><b>Aggregate Intrinsic</b><br /> <b>Value</b></td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center"> <b>(in thousands)</b></td> <td valign="bottom"> </td> </tr> <!-- End Table Head --><!-- Begin Table Body --> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of July 1, 2013</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,121,807</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.09</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Cancelled</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(74,396</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.55</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercised</p> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,250,000</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.85</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Outstanding as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,797,411</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.80</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.7</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">516</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> <p style="TEXT-INDENT: -1em; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; FONT-SIZE: 10pt"> Exercisable as of September 30, 2013</p> </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,332,274</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt"> </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">5.32</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"><font style="FONT-SIZE: 8pt">  </font></td> <td valign="bottom">$</td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double"> </p> </td> <td> </td> </tr> </table> </div>
</unis:ScheduleOfShareBasedCompensationStockOptionsActivityByEmployeesAndDirectorsTableTextBlock>
<unis:LeaseBuyoutRate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0" unitRef="pure" decimals="2" id="id_2375738_8F92B8CC-A7B2-4ECB-86A9-F596B2BD4DE4_1_0"> 0.15 </unis:LeaseBuyoutRate>
<us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_926396x955913" id="id_2375738_73C09F1D-AD87-4322-B4C6-40EF5A8DAA01_1003_3"> 2021-01-31 </us-gaap:DebtInstrumentMaturityDate>
<us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_926396x970115" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_1001_14"> 2021-01-31 </us-gaap:DebtInstrumentMaturityDate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x923140" id="id_2375738_C3EDCAFB-7CB1-4962-B0F7-07308047D417_1001_4"> P11M23D </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x923140_930809x924898" id="id_2375738_8EAFF92B-AD44-4E8C-BB42-4ED3A63351DE_1001_1"> P3Y </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x932953" id="id_2375738_C3EDCAFB-7CB1-4962-B0F7-07308047D417_2001_3"> P9M29D </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x932953_930809x924898" id="id_2375738_8EAFF92B-AD44-4E8C-BB42-4ED3A63351DE_2001_0"> P1Y </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x923434" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5005_800004"> 261000 </us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
<us-gaap:NetIncomeLoss contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x929313" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5004_700003"> -11244000 </us-gaap:NetIncomeLoss>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x930643" unitRef="shares" decimals="INF" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5001_400010"> 1305000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x930643" unitRef="shares" decimals="INF" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5001_400006"> 100500 </us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x930643" unitRef="shares" decimals="INF" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5001_400008"> 3512153 </us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x930643" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5001_500009"> 13000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x930643" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5001_500005"> 1000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x930643" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5001_500007"> 35000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x932586" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5003_600009"> 2221000 </us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x932586" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5003_600005"> 2635000 </us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
<us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x932586" unitRef="iso4217_USD" decimals="-3" id="id_2375738_2253F162-B133-45CD-B137-F922C19249E0_5003_600007"> 10633000 </us-gaap:StockIssuedDuringPeriodValueNewIssues>
<unis:ProceedsFromUpFrontNonRefundableFees contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_928294x1006168" unitRef="iso4217_EUR" decimals="-5" id="id_2375738_B8285C95-DB3E-4021-B062-C0880D70F56F_2_1"> 10000000 </unis:ProceedsFromUpFrontNonRefundableFees>
<unis:ProceedsFromUpFrontNonRefundableFees contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_928294x1006168" unitRef="iso4217_USD" decimals="-5" id="id_2375738_B8285C95-DB3E-4021-B062-C0880D70F56F_1_1"> 13000000 </unis:ProceedsFromUpFrontNonRefundableFees>
<unis:ProceedsForExclusivityFeesAndIndustrializationMilestone contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_928294x1006168" unitRef="iso4217_USD" decimals="-5" id="id_2375738_B8285C95-DB3E-4021-B062-C0880D70F56F_1_0"> 36400000 </unis:ProceedsForExclusivityFeesAndIndustrializationMilestone>
<unis:UnamortizedRevenueRecognized contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_928294x1006168" unitRef="iso4217_USD" decimals="-5" id="id_2375738_4AF28C1B-ECC9-41D1-AEE7-F517BA00FC61_2_0"> 2300000 </unis:UnamortizedRevenueRecognized>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_928305x923936" unitRef="shares" decimals="INF" id="id_2375738_9A5B1550-C1E9-4AE9-AFA8-C2F2F65CF816_1001_0"> 3147851 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_928305x924898" unitRef="shares" decimals="INF" id="id_2375738_5A963138-EC5B-4438-A512-C3FFB0EE3621_1001_1"> 495572 </us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_928305x924898" unitRef="shares" decimals="INF" id="id_2375738_5A963138-EC5B-4438-A512-C3FFB0EE3621_1001_0"> 6283164 </us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x923936" unitRef="shares" decimals="INF" id="id_2375738_8652DEB7-AF0D-4F69-AC75-6CA30AB1B512_1_3"> 4500 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x923936" unitRef="shares" decimals="INF" id="id_2375738_8652DEB7-AF0D-4F69-AC75-6CA30AB1B512_1_1"> 55000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x923936" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_E918207F-BB05-485A-9674-06536AE8DDBA_1_3"> 3.46 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x923936" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_E918207F-BB05-485A-9674-06536AE8DDBA_1_2"> 3.25 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x923936" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_E918207F-BB05-485A-9674-06536AE8DDBA_1_1"> 3.38 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x923936" unitRef="shares" decimals="INF" id="id_2375738_8652DEB7-AF0D-4F69-AC75-6CA30AB1B512_1_2"> 402750 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x926520" unitRef="pure" decimals="4" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_1_2"> 0.0154 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x926520" unitRef="pure" decimals="2" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_1_3"> 0.55 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x926520" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_1_4"> P5Y </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x926520" unitRef="pure" decimals="2" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_1_1"> 0.00 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x926520" unitRef="shares" decimals="INF" id="id_2375738_78D385D4-78A6-4AAF-BB84-3BFA37EDEF2F_1_0"> 300000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1022497" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_EF03F353-A443-4E98-B1CB-BEE6704D2988_1_1"> 5.55 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1022497" id="id_2375738_17859C2C-5196-41CF-93EC-6728D4B34A49_1_0"> P5Y8M12D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1022497" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_EF03F353-A443-4E98-B1CB-BEE6704D2988_1_2"> 1.85 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1022497" id="id_2375738_17859C2C-5196-41CF-93EC-6728D4B34A49_1_1"> P5Y3M18D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1022497" unitRef="shares" decimals="INF" id="id_2375738_A797CAC9-B14F-40C3-8662-D5E61F79623B_1_2"> 1250000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1022497" unitRef="shares" decimals="INF" id="id_2375738_A797CAC9-B14F-40C3-8662-D5E61F79623B_1_1"> 74396 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1031369" id="id_2375738_66319542-1064-484B-BD79-3E2E3FADBA0A_1_0"> P1Y2M12D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1031369" unitRef="shares" decimals="INF" id="id_2375738_AA8112E3-B667-463C-A821-C6EC6F31D4B1_1_1"> 300000 </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1031369" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_DB50016A-717F-4207-A6D7-809134EC1DDC_1_1"> 3.11 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1031369" unitRef="iso4217_USD_per_shares" decimals="2" id="id_2375738_DB50016A-717F-4207-A6D7-809134EC1DDC_1_2"> 1.85 </us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1031369" id="id_2375738_66319542-1064-484B-BD79-3E2E3FADBA0A_1_1"> P1Y2M12D </us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1031369" unitRef="shares" decimals="INF" id="id_2375738_AA8112E3-B667-463C-A821-C6EC6F31D4B1_1_2"> 55000 </us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
<us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1069470" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_2001_5"> 2020-10-31 </us-gaap:DebtInstrumentMaturityDate>
<us-gaap:DebtInstrumentMaturityDateDescription contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1073515" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_3001_11"> January 2021 through August 2021 </us-gaap:DebtInstrumentMaturityDateDescription>
<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1103291" unitRef="pure" decimals="4" id="id_2375738_2A2DB385-4CF9-44AF-A3E3-44FE7B7A9FF8_1001_0"> 0.0150 </us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
<unis:DebtInstrumentFloorInterestRateDuringPeriod contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1103291" unitRef="pure" decimals="4" id="id_2375738_2A2DB385-4CF9-44AF-A3E3-44FE7B7A9FF8_1001_1"> 0.0450 </unis:DebtInstrumentFloorInterestRateDuringPeriod>
<us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1107489" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_4001_2"> 2031-12-31 </us-gaap:DebtInstrumentMaturityDate>
<us-gaap:DebtInstrumentMaturityDate contextRef="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x961912" id="id_2375738_E3D4F013-66CF-4982-9EFC-525043F1EBEC_5001_8"> 2013-09-30 </us-gaap:DebtInstrumentMaturityDate>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x961912">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:OneTwoPointEightFivePercentSecuredLendingFacilityDueTwoZeroOneThreeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1107489">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:SixPointZeroZeroPercentMortgageLoansDueDecemberTwoZeroThreeOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1103291">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:MortgageTermNoteMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1073515">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:FourPointSevenFivePercentBankTermLoansDueJanuaryTwoZeroTwoOneThroughAugustTwoZeroTwoOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_931308x1069470">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:SixPointZeroZeroPercentMortgageLoansDueOctoberTwoZeroTwoZeroMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1031369">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"> unis:NonEmployeesWarrantMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_931284x1022497">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"> unis:EmployeesAndBoardMembersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x926520">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_929038x923936">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> us-gaap:RestrictedStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_928305x924898">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:EmployeeStockOptionMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_928305x923936">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:RestrictedStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_928294x1006168">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> unis:SanofiMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x932586">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x930643">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x929313">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_927592x923434">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x932953_930809x924898">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis"> us-gaap:EmployeeStockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x932953">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x923140_930809x924898">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis"> us-gaap:EmployeeStockOptionMember </xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_926437x923140">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_926396x970115">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:FivePointZeroZeroPercentCommonWealthOfPennsylvaniaFinancingAuthorityLoanDueJanuaryTwoZeroTwoOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0_926396x955913">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:CommonwealthOfPennsylvaniaFinancingAuthorityLoanMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20130930_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<startDate> 2013-07-01 </startDate>
<endDate> 2013-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20120930_0_929038x926520">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> us-gaap:StockOptionMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2012-07-01 </startDate>
<endDate> 2012-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20120930_0_928305x924898">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:EmployeeStockOptionMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2012-07-01 </startDate>
<endDate> 2012-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20120930_0_928305x923936">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"> us-gaap:RestrictedStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2012-07-01 </startDate>
<endDate> 2012-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_92_20120930_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<startDate> 2012-07-01 </startDate>
<endDate> 2012-09-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_31_20101231_0_926396x955913">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:CommonwealthOfPennsylvaniaFinancingAuthorityLoanMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2010-12-01 </startDate>
<endDate> 2010-12-31 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_31_20110831_0_924420x1135205">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> unis:SecuredLendingFacilityMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2011-08-01 </startDate>
<endDate> 2011-08-31 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_31_20101031_0_931308x930693">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> us-gaap:MortgagesMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2010-10-01 </startDate>
<endDate> 2010-10-31 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_31_20100131_0_930809x959754">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis"> unis:StockIncentivePlanMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2010-01-01 </startDate>
<endDate> 2010-01-31 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_31_20091031_0_926396x955913">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:CommonwealthOfPennsylvaniaFinancingAuthorityLoanMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2009-10-01 </startDate>
<endDate> 2009-10-31 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_30_20091130_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<startDate> 2009-11-01 </startDate>
<endDate> 2009-11-30 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_211_20100127_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<startDate> 2009-07-01 </startDate>
<endDate> 2010-01-27 </endDate>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x998218">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:MortgagesLoanMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x961912">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:OneTwoPointEightFivePercentSecuredLendingFacilityDueTwoZeroOneThreeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x1107489">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:SixPointZeroZeroPercentMortgageLoansDueDecemberTwoZeroThreeOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x1073515">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:FourPointSevenFivePercentBankTermLoansDueJanuaryTwoZeroTwoOneThroughAugustTwoZeroTwoOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_931308x1069470">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:SixPointZeroZeroPercentMortgageLoansDueOctoberTwoZeroTwoZeroMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_931284x1031369">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"> unis:NonEmployeesWarrantMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_931284x1022497">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"> unis:EmployeesAndBoardMembersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_929038x923936">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> us-gaap:RestrictedStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x932586">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x930643">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x929313">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x924490">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_927592x923434">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_926396x970115">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:FivePointZeroZeroPercentCommonWealthOfPennsylvaniaFinancingAuthorityLoanDueJanuaryTwoZeroTwoOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0_926396x959606">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:OtherLongTermDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130630_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<instant> 2013-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20120630_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<instant> 2012-06-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x998218">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:MortgagesLoanMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x961912">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:OneTwoPointEightFivePercentSecuredLendingFacilityDueTwoZeroOneThreeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1107489">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:SixPointZeroZeroPercentMortgageLoansDueDecemberTwoZeroThreeOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1073515">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:FourPointSevenFivePercentBankTermLoansDueJanuaryTwoZeroTwoOneThroughAugustTwoZeroTwoOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_931308x1069470">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:SixPointZeroZeroPercentMortgageLoansDueOctoberTwoZeroTwoZeroMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1031369">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"> unis:NonEmployeesWarrantMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_931284x1022497">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"> unis:EmployeesAndBoardMembersMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_929038x923936">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis"> us-gaap:RestrictedStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_928294x1006168">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis"> unis:SanofiMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x932586">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AdditionalPaidInCapitalMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x930643">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:CommonStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x929313">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:RetainedEarningsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x924490">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:TreasuryStockMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_927592x923434">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis"> us-gaap:AccumulatedOtherComprehensiveIncomeMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_926437x932953">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MinimumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_926437x923140">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_926396x970115">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:FivePointZeroZeroPercentCommonWealthOfPennsylvaniaFinancingAuthorityLoanDueJanuaryTwoZeroTwoOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0_926396x959606">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:OtherLongTermDebtMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20130930_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<instant> 2013-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20120930_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<instant> 2012-09-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20101231_0_926396x955913">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis"> unis:CommonwealthOfPennsylvaniaFinancingAuthorityLoanMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2010-12-31 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20091130_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<instant> 2009-11-30 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20110831_0_924420x1135205">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis"> unis:SecuredLendingFacilityMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2011-08-31 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20131108_0">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
</entity>
<period>
<instant> 2013-11-08 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20121031_0_926437x923140">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RangeAxis"> us-gaap:MaximumMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2012-10-31 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20101031_0_931308x960914">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:MortgageTermNoteOneMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2010-10-31 </instant>
</period>
</context>
<context id="eol_PE815564--1310-Q0008_STD_0_20101031_0_931308x1134098">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001476170 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis"> unis:MortgageTermNoteTwoMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant> 2010-10-31 </instant>
</period>
</context>
<unit id="iso4217_USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="shares">
<measure> shares </measure>
</unit>
<unit id="pure">
<measure> pure </measure>
</unit>
<unit id="iso4217_USD_per_shares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<unit id="iso4217_AUD_per_shares">
<divide>
<unitNumerator>
<measure> iso4217:AUD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<unit id="Product">
<measure> unis:Product </measure>
</unit>
<unit id="Note">
<measure> unis:Note </measure>
</unit>
<unit id="iso4217_EUR">
<measure> iso4217:EUR </measure>
</unit>
</xbrl>

↑Top
Filing Submission 0001193125-13-438524   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., Apr. 19, 2:09:37.1pm ET